David L. Hill
Corporate Officer/Principal at American Association of Bioanalysts
Profile
David L.
Hill is the founder of California Central Coast Ivf Laboratory founded in 2018.
He is currently an Assistant Professor at David Geffen School of Medicine and a Member of American Association of Bioanalysts.
He was an Independent Director at Stellar Biotechnologies, Inc. and served as the Scientific Director at Art Reproductive Center from 1999 to 2016.
Dr. Hill has an undergraduate and graduate degree from California Polytechnic State University and a doctorate from The University of Connecticut School of Medicine, which he received in 1983.
David L. Hill active positions
| Companies | Position | Start |
|---|---|---|
| American Association of Bioanalysts | Corporate Officer/Principal | - |
| David Geffen School of Medicine | Corporate Officer/Principal | - |
Former positions of David L. Hill
| Companies | Position | End |
|---|---|---|
| Art Reproductive Center | Chief Tech/Sci/R&D Officer | 2016-11-30 |
| California Central Coast Ivf Laboratory | Corporate Officer/Principal | - |
Stellar Biotechnologies, Inc.
 Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Director/Board Member | - |
Training of David L. Hill
| California Polytechnic State University (San Luis Obispo) | Graduate Degree |
| The University of Connecticut School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Stellar Biotechnologies, Inc.
Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |
| Art Reproductive Center | |
| American Association of Bioanalysts | |
| California Central Coast Ivf Laboratory |
- Stock Market
- Insiders
- David L. Hill